Question to the Department of Health and Social Care:

To ask His Majesty's Government when they expect the NICE assessment of Evusheld to be completed; and whether, if approved, the treatment will be provided for patients in England this winter.

The National Institute for Health and Care Excellence (NICE) is conducting a Health Technology Evaluation of Evusheld, which will provide guidance on the use of Evusheld in the National Health Service. This evaluation is in development with publication expected in spring 2023. If the NICE recommends its use as a pre-exposure prophylactic is clinically and cost effective, the NHS will make Evusheld available as appropriate.